Palladium(II) complexes with 5-methyl-5-(4-pyridyl)-2,4-imidazolidenedione

Two new palladium(II) complexes with 5-methyl-5-(4-pyridyl)-2,4-imidazolidenedione(mpyh) were synthesized: cis-[Pd(mpyh)₂Cl₂]·H₂O and cis-[Pd(mpyh)₂Br₂]·2H₂O. The molecular formulae of the complexes were confirmed by elemental analysis, IR, ¹H NMR spectra and DTA study. The ligand is coordinated to the palladium ion with N-atom of the pyridine ring. The spectroscopic data indicate a square planar geometry with two N-pyridine atoms and two halogene anions in cis position. The final product of the thermal decomposition of cis-[Pd(mpyh)₂Cl₂]·H₂O is metallic Pd, whereas for cis-[Pd(mpyh)₂Br₂]·2H₂O the residue consists of metallic Pd and C. The cytotoxic effects of the complexes were examined in vitro on some human tumor cell lines. The cis-[Pd(mpyh)₂Cl₂]·H₂O proved to be more active as compared to the cis-[Pd(mpyh)₂Br₂]·2H₂O.     

Hydrolysis of the amide bond in N-acetylated l-methionylglycine catalyzed by various platinum(II) complexes under physiologically relevant conditions

The hydrolytic reactions between various Pt(II) complexes of the type [Pt(L)Cl₂] and [Pt(L)(CBDCA-O,O′] (L is ethylenediamine, en; (±)-trans-1,2-diaminocyclohexane, dach; (±)-1,2-propylenediamine, 1,2-pn and CBDCA is the 1,1-cyclobutanedicarboxylic anion) and the N-acetylated l-methionylglycine dipeptide (MeCOMet-Gly) were studied by ¹H NMR spectroscopy. All reactions were realized at 37 °C with equimolar amounts of the Pt(II) complex and the dipeptide at pH 7.40 in 50 mM phosphate buffer in D₂O. Under these experimental conditions, a very slow cleavage of the Met-Gly amide bond was observed and this hydrolytic reaction proceeds through the intermediate [Pt(L)(H₂O)(MeCOMet-Gly-S)]⁺ complex. In general, it can be concluded that faster hydrolytic cleavage of the MeCOMet-Gly dipeptide was observed in the reaction with the chloride complex than with corresponding CBDCA Pt(II) complexes. The steric effects of the Pt(II) complex on the hydrolytic cleavage of the amide bond in the MeCOMet-Gly dipeptide were also investigated by ¹H NMR spectroscopy. It was found that the rate of hydrolysis decreases as the steric bulk of the CBDCA and chlorido Pt(II) complexes increase (en > 1,2-pn > dach). These results contribute to a better understanding of the toxic side effects of Pt(II) antitumor drugs and should be taken into consideration when designing new potential Pt(II) antitumor drugs with preferably low toxic side effects.     

Cationic (fluoromesityl)palladium(II) complexes

Halide abstraction from [Pd(μ-Cl)(Fmes)(NCMe)]₂ (Fmes = 2,4,6-tris(trifluoromethyl)phenyl or nonafluoromesityl) with TlBF₄ in CH₂Cl₂/MeCN gives [Pd(Fmes)(NCMe)₃]BF₄, which reacts with monodentate ligands to give the monosubstituted products trans-[Pd(Fmes)L(NCMe)₂]BF₄ (L = PPh₃, P(o-Tol)₃, 3,5-lut, 2,4-lut, 2,6-lut; lut = dimethylpyridine), the disubstituted products trans-[Pd(Fmes)(NCMe)(PPh₃)₂]BF₄, cis-[Pd(Fmes)(3,5-lut)₂(NCMe)]BF₄, or the trisubstituted products [Pd(Fmes)L₃]BF₄ (L = CN^tBu, PHPh₂, 3,5-lut, 2,4-lut). Similar reactions using bidentate chelating ligands give [Pd(Fmes)(L-L)(NCMe)]BF₄ (L-L = bipy, tmeda, dppe, OPPhPy₂-N,N′, (OH)(CH₃)CPy₂-N,N′). The complexes trans-[Pd(Fmes)L₂(NCMe)]BF₄ (L = PPh₃, tht) (tht = tetrahydrothiophene) and [Pd(Fmes)(L-L)(NCMe)]BF₄ (L-L = bipy, tmeda) were obtained by halide extraction with TlBF₄ in CH₂Cl₂/MeCN from the corresponding neutral halogeno complexes trans-[Pd(Fmes)ClL₂] or [Pd(Fmes)Cl(L-L)]. The aqua complex trans-[Pd(Fmes)(OH₂)(tht)₂]BF₄ was isolated from the corresponding acetonitrile complex. Overall, the experimental results on these substitution reactions involving bulky ligands suggest that thermodynamic and kinetic steric effects can prevail affording products or intermediates different from those expected on purely electronic considerations. Thus,water, whether added on purpose or adventitious in the solvent, frequently replaces in part other better donor ligands, suggesting that the smaller congestion with water compensates for the smaller M-OH₂ bond energy.     

Quantum chemical calculations of stability constants: study of ligand effects on the relative stability of Pd(II)�Cpeptide complexes

Replacement of [Pd(H₂O)₄]²⁺ by cis-[Pd(en)(H₂O)₂]²⁺, [PdCl₄]^2?, and [Pd(NH₃)₄]²⁺ on the hydrolytic cleavage of the Ace-Ala-Lys-Tyr-Gly?CGly-Met-Ala-Ala-Arg-Ala peptide is theoretically investigated by using different quantum chemical methods both in the gas phase an in water solution. First, we carry out a series of validation calculations on small Pd(II) complexes by computing high-level ab initio [MP2 and CCSD(T)] and Density Functional Theory (B3LYP) electronic energies while solvent effects are taken into account by means of a Poisson-Boltzmann continuum model coupled with the B3LYP method. After having assessed the actual performance of the DFT calculations in predicting the stability constants for selected Pd(II)-complexes, we compute the relative free energies in solution of several Pd(II)?Cpeptide model complexes. By assuming that the reaction of the peptide with cis-[Pd(en)(H₂O)₂]²⁺, [Pd(Cl)₄]^2?, and [Pd(NH₃)₄]²⁺ would lead to the initial formation of the respective peptide-bound complexes, which in turn would evolve to afford a hydrolytically active complex [Pd(peptide)(H₂O)₂]²⁺ through the displacement of the en, Cl^?, and NH₃ ligands by water, our calculations of the relative stability of these complexes allow us to rationalize why [Pd(H₂O)₄]²⁺ and [Pd(NH₃)₄]²⁺ are more reactive than cis-[Pd(en)(H₂O)₂]²⁺ and [PdCl₄]^2? as experimentally found.     

Bis(saccharinato)palladium(II) and platinum(II) complexes with 2,2′-bipyridine: Syntheses,structures, spectroscopic,fluorescent and thermal properties

New palladium(II) and platinum(II) complexes, cis-[Pd(bpy)(sac)₂] (1) and cis-[Pt(bpy)(sac)₂] (2), where sac = saccharinate, bpy = 2,2′-bipyridine, have been synthesized and characterized by elemental analysis, UV–Vis, IR, ¹H NMR and ¹³C NMR. The structures of the DMSO solvated complexes are determined by X-ray diffraction. Both complexes are isomorphous and the metal ions are coordinated by two N-bonded sac ligands, and two nitrogen atoms of pyridyl groups of bpy in a cis fashion. The mononuclear species interact each other through weak intermolecular C–H?O hydrogen bonds, C–H?π and π?π interactions leading to three-dimensional supramolecular networks. All complexes exhibit a high thermal stability in the solid state, and are fluorescent in the solution.     

Synthesis and characterization of some potential antitumor palladium(II) complexes of 2-aminomethylbenzimidazole and amino acids

The stoichiometry and stability constants of complexes formed between [Pd(AMBI)(H₂O)₂]²⁺ (AMBI?=?2-(aminomethyl)-benzimidazole) with some selected bio-relevant ligands containing different functional groups were investigated at 25°C and 0.1?mol?L^?1 ionic strength. The ligands used are imidazole, cysteine, glutathione (GSH), threonine, aspartic acid, 1,1-cyclobutane dicarboxylic acid (CBDCA) and lysine. The stoichiometry and stability constants of the formed complexes were reported and the concentration distribution of the various complex species was evaluated as a function of pH. The results show ring opening of CBDCA and monodentate complexation of the DNA constituent with the formation of [Pd(AMBI)(CBDCA–O)DNA], where (CBDCA–O) represents cyclobutane dicarboxylate coordinated by one carboxylate oxygen. The equilibrium constant of the displacement reaction of coordinated inosine, as a typical DNA constituent, by glutathione, as a typical thiol ligand, was investigated. The effect of dioxane on the formation constant of CBDCA with Pd(AMBI)²⁺ is reported. Five new palladium(II) complexes of the formula [Pd(AMBI)(AA)] ^{n +} (where AMBI?=?2-aminomethyl benzimidazole, AA is an anion of glycine, alanine, cysteine, methionine, and serine) have been synthesized. These palladium(II) complexes have been ascertained by elemental, molar conductance, infrared and ¹H-NMR spectroscopy. The isolated Pd(II) complexes were screened for their antibacterial and cytotoxic activities and the results are discussed.     

Synthesis,characterization, and cytotoxicity of platinum(II)/palladium(II) complexes with 4-toluenesulfonyl-L-amino acid dianion and diimine/diamine

Eight new platinum(II)/palladium(II) complexes with 4-toluenesulfonyl-L-amino acid dianion and diimine/diamine ligands, [Pd(en)(Tsile)]·H₂O (1), [Pd(bipy)(Tsile)] (2), [Pd(bipy)(Tsthr)]·0.5H₂O (3), [Pd(phen)(Tsile)]·0.5H₂O (4), [Pd(phen)(Tsthr)]·H₂O (5), [Pd(bqu)(Tsthr)]·1.5H₂O (6), [Pt(en)(Tsser)] (7), and [Pt(en)(Tsphe)]·H₂O (8), have been synthesized and characterized by elemental analyses, ¹H NMR and mass spectrometry. The crystal structure of 7 has been determined by X-ray diffraction. Cytotoxicities were tested by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and sulforhodamine B assays. The complexes exert cytotoxicity against HL-60, Bel-7402, BGC-823, and KB cell lines with 4 having the best cytotoxicity against HL-60, Bel-7402, and BGC-823 cell lines; the compounds are less cytotoxic than cisplatin.     

Synthesis, spectroscopy and structures of palladium(II) and platinum(II) complexes containing mercapto-o-carborane

The reactions of [M₂Cl₂(μ-Cl)₂(PMe₂Ph)₂] with mercapto-o-carboranes in the presence of pyridine afforded mono-nuclear complexes of composition, [MCl(SCb°R)(py)(PMe₂Ph)] (M = Pd or Pt; Cb° = o-C₂B₁₀H₁₀; R = H or Ph). The treatment of [PdCl₂(PEt₃)₂] with PhCb°SH yielded trans-[Pd(SCb°Ph)₂(PEt₃)₂] (4) which when left in solution in the presence of pyridine gave another substitution product, [Pd(SCb°Ph)₂(py)(PEt₃)] (5). The structures of [PdCl(SCb°Ph)(py)(PMe₂Ph)] (1), [Pd(SCb°Ph)₂(PEt₃)₂] (4) and [Pd(SCb^oPh)₂(py)(PEt₃)] (5) were established unambiguously by X-ray crystallography. The palladium atom in these complexes adopts a distorted square-planar configuration with neutral donor atoms occupying the trans positions. Thermolysis of [PdCl(SCb°)(py)(PMe₂Ph)] (2) in TOPO (trioctylphosphine oxide) at 200 °C gave nanocrystals of TOPO capped Pd₄S which were characterized by XRD pattern and SEM.     

Synthesis, characterization and cytotoxicity of some palladium(II), platinum(II), rhodium(I) and iridium(I) complexes of ferrocenylpyridine and related ligands. Crystal and molecular structure of trans-dichlorobis(3-ferrocenylpyridine)palladium(II)

The preparation of a series of ferrocenyl nitrogen donor ligands including ferrocenylpyridines, ferrocenylphenylpyridines and 1,1^′-di(2-pyridyl)ferrocene is described. Coordination studies of the substituted pyridines (L) were carried out with platinum, palladium, rhodium and iridium. This resulted in the preparation of the following types of complexes: [MCl(CO)₂(L)] and [M(cod)(L)₂]ClO₄ where M=Rh or Ir, cod=1,5-cyclooctadiene; [M^′Cl₂(L)₂] where M^′=Pt or Pd. The X-ray crystal structure of trans-dichlorobis(3-ferrocenylpyridine)palladium was obtained. The complexes were screened for activity against two human cancer cell lines. At least two of the complexes displayed growth inhibition similar to that of the widely used chemotherapeutic agent, cisplatin.     

Synthesis and characterization of cyclometallated palladium(II) and platinum(II) complexes with amide-thiolate ligands

The redox reaction of bis(2-benzamidophenyl) disulfide (H₂L-LH₂) with [Pd(PPh₃)₄] in a 1:1 ratio gave mononuclear and dinuclear palladium(II) complexes with 2-benzamidobenzenethiolate (H₂L⁻), [Pd(H₂L-S)₂(PPh₃)₂] (1) and [Pd₂(H₂L-S)₂ (μ-H₂L-S)₂(PPh₃)₂] (2). A similar reaction with [Pt(PPh₃)₄] produced only the corresponding mononuclear platinum(II) complex, [Pt(H₂L-S)₂(PPh₃)₂] (3). Treatment of these complexes with KOH led to the formation of cyclometallated palladium(II) and platinum(II) complexes, [Pd(L-C,N,S)(PPh₃)]⁻ ([4]⁻) and [Pt(L-C,N,S) (PPh₃)]⁻ ([5]⁻). The molecular structures of 2, 3 and [4]⁻ were determined by X-ray crystallography.     

Calculations of microconstants and equilibrium formation constants for platinum(II) and palladium(II) halide complexes in solution

Distribution diagrams and formation functions for halide complexes [M(H₂O)_{4 ? n} Cl _n ]^{2 ? n} (M = Pt(II) or Pd(II)) and [PdCl_{4 ? n} Br _n ]^2? (n = 0?C4) in solution are analyzed in terms of the matrix model. Equilibrium constants for binding the first ligand $\left( {\bar K} \right)$ and corrections for the mutual influence between ligands (??) in the course of complex formation in solution are calculated. In examples analyzed, the substitution of chloride ion for water in the coordination sphere of platinum(II) and palladium(II) is an anti-cooperative process. The substitution of bromide ion for chloride ion in the coordination sphere of [PdCl₄]^2? is weakly cooperative. Quantum-chemical calculations show that platinum(II) and palladium(II) cis-bisaquadichloro complexes in the gas phase are thermodynamically less stable than trans-isomers. The cis-trans isomerization constants in the gas phase calculated by the DFT method and those found for solutions using the matrix model have the same order of magnitude.     

Cyclic acyl complexes of palladium(II). Synthesis and NMR spectroscopy of acyl complexes derived from quinoline-8-carbaldehyde and 2-(dimethylamino)benzaldehyde

The room temperature syntheses of new chelating acyl palladium(II) complexes, [Pd(μ-Cl)(C(O)C₉H₆N)]₂ and [Pd(μ-Cl)(C(O)C₆H₄N(CH₃)₂]₂, derived from quinoline-8-carbaldehyde and 2-(dimethylamino)banzaldehyde are described. These chloro bridged dimers may be cleaved with neutral phosphine and nitrogen ligands, L, to give the monomeric [PdCl(C(O)C₉H₆N)L] and [PdCl(C(O)C₆H₄N(CH₃)₂)L] compounds. ¹H-, ¹³C- and ³¹P-NMR data for the new complexes are reported.     

A quantum chemical consideration of ligand exchange in palladium(ii) aqueous and chloride complexes

The behavior of potassium tetrachloropalladate(II) in media simulating biological fluids has been studied. In aqueous solutions of NaCl, the aquation rate is higher than the rate of chloro ligand introduction into the internal coordination sphere of palladium. In HCl solutions, on the contrary, the process of palladium chloro complex formation predominates. The latter is apparently due to protonation of water molecules composing aqua complexes. By means of the ZINDO/1 method, the substitution of ligands – water molecules and hydronium ion – in planar complexes of palladium(II) by chloride ion has been investigated. All complexes containing H₂O and H₃O⁺ ligands, other than [Pd(H₂O)₄]²⁺, have intramolecular hydrogen bonds. In [Pd(H₂O)₃(H₃O)]³⁺ and trans-[Pd(H₂O)₂(H₃O)Cl]²⁺, a “non-classic” symmetric hydrogen bond O ··· H ··· O is established (ZINDO/1, RHF/STO-6G*). By the first three steps the substitution of hydronium ion in the internal sphere of palladium atom is more favorable thermodynamically, compared to water molecules. Logarithms of stepwise stability constants of palladium(II) chloride complexes correlate linearly to enthalpies (ZINDO/1, PM3) of water substitution by chloride ion.     

Synthesis,spectral and thermal studies on dicarboxylate-bridged palladium(II) coordination polymers. Part II

The synthesis and thermal behavior of the new [Pd(fum)(bipy)] _n ·2nH₂O (1), [Pd(fum)(bpe)] _n ·nH₂O (2) and [Pd(fum)(pz)] _n ·3nH₂O (3) {bipy = 4,4′-bipyridine, bpe = 1,2-bis(4-pyridyl)ethene and pz = pyrazine} fumarate complexes are described in this work as well their characterization by IR and ¹³C CPMAS NMR spectroscopies. TG curves showed that the compounds released organic ligands and lattice water molecules in the temperature range of 46–491 °C. In all the cases, metallic palladium was identified as the final residue.     

Thermally-reversible photoisomerization of trans-dinitrobis(tri-N-propylphosphine)palladium(II)

UV irradiation of trans-dinitrobis(tri-n-propylphosphine)palladium(II) in MeOH yields a photostationary trans-cis mixture which reverts quantitatively in the dark to the trans-form. The cis-isomer, which can be isolated in crystalline form by irradiation of trans-species in n-hexane, has been characterized by UV, IR ¹H and ³¹P NMR spectroscopy. Irradiation of a 1/1 mixture of trans-[(PBu₃ⁿ)₂Pd(NO₂)₂] and trans-[(PPr₃ⁿ)₂Pd(NO₂)₂] gives almost entirely a 1/1 mixture of the corresponding cis-isomer, indicating an intramolecular process.     

Salen-type nickel(II), palladium(II) and copper(II) complexes having chiral and racemic camphoric diamine components

Chiral and racemic Salen-type Schiff-base ligands (H₂L¹, H₂L² and H₂L³), condensed between D-(+)- and D,L-camphoric diamine (also known as (1R,3S)-1,2,2-trimethylcyclopentane-1,3-diamine) and 2-hydroxybenzaldehyde or 3,5-dibromo-2-hydroxybenzaldehyde with a 1:2 molar ratio, have been synthesized and characterized. A series of new nickel(II), palladium(II) and copper(II) complexes of these chiral and racemic ligands exhibiting different coordination number (4, 5 and 6) have been characterized with the formulae [NiL¹]·CH₃OH (3), [NiL¹]·H₂O (4), [NiL²] (5), [PdL²] (6), [Cu₂(L²)₂(H₂O)] (7) and [NiL³(DMF)(H₂O)] (8). Different solvent molecules in 3 and 4 (methanol and water molecules) as well as different apical ligands in 7 and 8 (water and DMF molecules) are involved in different O–H···O hydrogen bonding interactions to further stabilize the structures. UV–Vis (UV–Vis), circular dichroism (CD) spectra and thermogravimetric (TG) analyses for the metal complexes have also been carried out.     

Synthesis and structure of highly substituted pyrazole ligands and their complexes with platinum(II) and palladium(II) metal ions

Reaction of 3-methoxycarbonyl-2-methyl- or 3-dimethoxyphosphoryl-2-methyl-substituted 4-oxo-4H-chromones 1 with N-methylhydrazine resulted in the formation of isomeric, highly substituted pyrazoles 4 (major products) and 5 (minor products). Intramolecular transesterification of 4 and 5 under basic conditions led, respectively, to tricyclic derivatives 7 and 8. The structures of pyrazoles 4a (dimethyl 2-methyl-4-oxo-4H-chromen-3-yl-phosphonate) and 4b (methyl 4-oxo-2-methyl-4H-chromene-3-carboxylate) were confirmed by X-ray crystallography. Pyrazoles 4a and 4b were used as ligands (L) in the formation of ML₂Cl₂ complexes with platinum(II) or palladium(II) metal ions (M). Potassium tetrachloroplatinate(II), used as the metal ion reagent, gave both trans-[Pt(4a)₂Cl₂] and cis-[Pt(4a)₂Cl₂], complexes with ligand 4a, and only cis-[Pt(4b)₂Cl₂] isomer with ligand 4b. Palladium complexes were obtained by the reaction of bis(benzonitrile)dichloropalladium(II) with the test ligands. trans-[Pd(4a)₂Cl₂] and trans-[Pd(4b)₂Cl₂] were the exclusive products of these reactions. The structures of all the complexes were confirmed by IR, ¹H NMR and FAB MS spectral analysis, elemental analysis and Kurnakov tests.     

New biimidazole and bibenzimidazole derivatives: mono and binuclear palladium(II) or platinum(II) complexes and heterobinuclear palladium(II)-rhodium(I) or platinum(II)-rhodium(I) complexes

Novel neutral biimidazolate or bibenzimidazolate palladium(II) and platinum(II) complexes of the type M(NN)₂(dpe) [M = Pd, Pt; (NN)₂^2? = BiIm^2?, BiBzIm^2?. dpe = 1,2-bis(diphenylphosphino) ethane] have been obtained by reacting MCl₂(dpe) with TI₂(NN)₂. Complexes M(NN)₂(dpe) which are Lewis bases react with HClO₄ or [M(dpe)(Me₂CO)₂](ClO₄)₂ to yield, respectively, mononuclear cationic complexes of general formula [M{H₂(NN)₂](dpe) (M = Pd, Pt; H₂(NN)₂ = H₂BiIm, H₂BiBzIm) and homobinuclear palladium(II) or platinum(II) cationic complexes of the type [M₂{μ - (NN)₂}(dpe)₂](ClO₄)₂. Reactions of M(BiBzIm)(dpe) with [Rh(COD) (Me₂CO)_X](ClO₄) render similar heterobinuclear palladium(II)-rhodium(I) and platinum(II)-rhodium(I) cationic complexes, of general formula [(dpe)M(μ-BiBzIm)Rh(COD)](ClO₄) (M = Pd, Pt; COD = 1,5-cyclooctadiene). Di- and mono-carbonyl derivatives [(dpe)M(μ-BiBzIm)Rh(CO)L](ClO₄) (M = Pd, Pt; L = CO, PPh₃) have also been prepared. The structures of the resulting complexes have been elucidated by conductance studies and IR spectroscopy.     

Novel planar chiral phosphite: Preparation and use in the synthesis of Pd(II) complexes and in Pd-catalyzed allylic alkylation

The planar chiral diaryl phosphorimidite ligand containing additional C-stereocenters and neutral and cationic palladium(II) chelates with this ligand, cis-[Pd(η²-P,N)Cl₂] and [Pd(Allyl)(η²-P,N)]BF₄, were synthesized for the first time. The possibility of using these compounds in asymmetric allylic alkylation of 1,3-diphenylallyl acetate with dimethyl malonate in an optical yield of up to 73% was demonstrated.     

Carbamoyl and alkoxycarbonyl complexes of palladium(II) and platinum(II)

Carbamoyl and alkoxycarbonyl complexes of palladium(II) and platinum(II) of the type M(pnp)(CONHR)Cl (pnp = 2,6-bis(diphenylphosphinomethyl)pyridine; M Pd, R  C₆H₅, p-CH₃C₆H₄, p-CH₃OC₆H₄, C₆H₁₁, t-Bu; M  Pt, R  C₆H₅), Pd(pnp)[CON(Pr)₂]Cl (Pr = propyl), M(pnp)(COOR)Cl (M  Pd, R  C₆H₅, CH₃; M  Pt, R  CH₃), Pd(pnp)(COOCH₃)₂ result from reaction of M(pnp)Cl₂ with carbon monoxide and amines or alkoxides at room temperature and atmospheric pressure.The carbamoyl complexes react with bases to give urethane or diphenylurea depending upon the experimental conditions.